Patients with III and IV category of the Bethesda System under levothyroxine non-suppressive therapy have a lower rate of thyroid malignancy

Thyroid nodules (TNs) assigned to the Bethesda System categories III and IV include numerous clinical characteristics, which increase or decrease the risk of malignancy. However, there are very few data regarding the influence of TSH non-suppressive thyroid hormone therapy (NSTHT) on the risk of mal...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaliszewski, Krzysztof, Diakowska, Dorota, Wojtczak, Beata, Sutkowski, Krzysztof, Knychalski, Bartłomiej, Forkasiewicz, Zdzisław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557829/
https://www.ncbi.nlm.nih.gov/pubmed/31182752
http://dx.doi.org/10.1038/s41598-019-44931-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557829/
https://www.ncbi.nlm.nih.gov/pubmed/31182752
http://dx.doi.org/10.1038/s41598-019-44931-8

Ejemplares similares